z-logo
open-access-imgOpen Access
Regulation of Immune Responses by Histone Deacetylase Inhibitors
Author(s) -
Paul V. Licciardi,
Tom C. Karagiannis
Publication year - 2012
Publication title -
isrn hematology
Language(s) - English
Resource type - Journals
eISSN - 2090-4428
pISSN - 2090-441X
DOI - 10.5402/2012/690901
Subject(s) - epigenetics , histone deacetylase , epigenetic regulation of neurogenesis , biology , histone , hdac11 , acetylation , immune system , histone deacetylase 5 , chromatin , dna methylation , chromatin remodeling , cancer epigenetics , microbiology and biotechnology , cancer research , genetics , histone methyltransferase , gene expression , gene
Both genetic and epigenetic factors are important regulators of the immune system. There is an increasing body of evidence attesting to epigenetic modifications that influence the development of distinct innate and adaptive immune response cells. Chromatin remodelling via acetylation, methylation, phosphorylation, and ubiquitination of histone proteins as well as DNA, methylation is epigenetic mechanisms by which immune gene expression can be controlled. In this paper, we will discuss the role of epigenetics in the regulation of host immunity, with particular emphasis on histone deacetylase inhibitors. In particular, the role of HDAC inhibitors as a new class of immunomodulatory therapeutics will also be reviewed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom